Keyphrases
Cytomegalovirus
100%
Valganciclovir
100%
Renal Allograft Outcomes
100%
Graft Loss
50%
Body Mass Index
25%
Transplantation
25%
Increased Incidence
25%
Renal Function
25%
Between-group
25%
Acute Rejection
25%
Well-defined
25%
Patient Survival
25%
Renal Transplantation
25%
Therapeutic Strategies
25%
Blood Pressure Changes
25%
Multicenter Randomized Controlled Trial
25%
Graft Survival
25%
Renal Transplant
25%
Preemptive Therapy
25%
Cardiovascular Events
25%
Adult Recipients
25%
Date of Death
25%
Interstitial Fibrosis Tubular Atrophy
25%
Death Loss
25%
New Onset Diabetes Mellitus after Transplantation
25%
Goal Blood Pressure
25%
Medicine and Dentistry
Cytomegalovirus
100%
Kidney Allograft
100%
Valganciclovir
100%
Graft Failure
50%
Cardiovascular System
25%
Body Mass Index
25%
Kidney Function
25%
Randomized Controlled Trial
25%
Blood Pressure
25%
Graft Survival
25%
Acute Graft Rejection
25%
Kidney Transplantation
25%
Diabetes Mellitus
25%
Idiopathic Pulmonary Fibrosis
25%